Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
ViroMissile, Inc.
Pfizer
Tizona Therapeutics, Inc
Adaptimmune
Novartis
TScan Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Actym Therapeutics, Inc.
Memgen, Inc.
MacroGenics
Providence Health & Services
Genentech, Inc.
University of California, San Diego
DEKA Biosciences
Columbia University
Thomas Jefferson University
Revolution Medicines, Inc.
Checkpoint Therapeutics, Inc.
Inhibrx Biosciences, Inc
Xencor, Inc.
Pfizer
Celldex Therapeutics
Adaptimmune
Apexigen America, Inc.
Seagen Inc.
Fate Therapeutics
Prelude Therapeutics
Quadriga Biosciences, Inc.
Xencor, Inc.
Ludwig Institute for Cancer Research
Revolution Medicines, Inc.
Imperial College London
Pfizer
AbbVie
Incyte Corporation
MacroGenics
Mie University
Tocagen Inc.
IGF Oncology, LLC
University of Illinois at Chicago
Takara Bio Inc.
Mie University
Lytix Biopharma AS
sigma-tau i.f.r. S.p.A.
Celldex Therapeutics
Santa Maria Biotherapeutics
BIND Therapeutics
Life Molecular Imaging SA
University of Chicago